View Article

Abstract

Pharmaceuticals are essential in emergency response, yet large volumes of unused, expired, or damaged medical products accumulate during and after crises. Inadequate disposal of these pharmaceuticals poses critical risks to human health, ecosystems, and antimicrobial resistance patterns. This review synthesizes WHO and international guidelines on safe pharmaceutical waste management in emergencies, highlighting procedures for classification, segregation, transportation, treatment, and final disposal. The article also examines emerging technologies, operational challenges in low-resource settings, environmental impacts, and the responsibilities of governments, humanitarian agencies, and health professionals. Recommendations for strengthening emergency preparedness, waste-minimisation strategies, and post-disaster recovery frameworks are also provided.

Keywords

pharmaceutical waste, emergency response, WHO guidelines, drug disposal, humanitarian crises, environmental safety.

Introduction

Emergencies including natural disasters, disease outbreaks, conflicts, and humanitarian crises dramatically increase the demand for pharmaceuticals. Large volumes of medicines are donated, procured, or distributed rapidly to meet urgent health needs. While these interventions save lives, they also generate significant amounts of unwanted pharmaceuticals, including: Expired, medicines, partially used products, Contaminated or damaged pharmaceuticals, Overstocked donations, Returned or unused drugs from field operations, Temperature-compromised medicines (cold-chain failures) [1].

The disposal of these substances becomes especially challenging in crisis environments, where infrastructure is disrupted and health systems are overwhelmed. If improperly handled, pharmaceutical waste can contaminate soil and water, increase toxicity risks, promote antimicrobial resistance (AMR), and endanger civilians, health workers, and the environment.

Recognising these risks, the World Health Organization (WHO) issued the foundational document “Guidelines for Safe Disposal of Unwanted Pharmaceuticals in and after Emergencies.” These guidelines serve as a global reference for governments, humanitarian organisations, pharmacists, and emergency responders [2].

BACKGROUND AND RATIONALE [2-3].

Pharmaceutical waste management is a challenge even in stable health systems, but during emergencies, several factors amplify the problem:

1. Surge in Donations and Overstocking

  • Humanitarian emergencies often lead to an influx of unsolicited pharmaceutical donations. Many donated drugs may be:
  • Near expiry
  • Unsuitable for local disease patterns
  • Not registered in the recipient country
  • Packaged in unfamiliar languages
  • Non-essential or in excessive quantity
  • These medicines cannot be used safely and thus accumulate as waste.

2. Damage from Disaster Events

Floods, fires, earthquakes, and cyclones can destroy storage facilities. Water-damaged, heat-exposed, or contaminated medicines become unsafe for use.

3. Breakdown of Supply Chains

In emergencies, transport and storage systems collapse. Cold-chain failures render vaccines and insulin unusable, contributing to pharmaceutical debris.

4. Improper Storage Conditions in Field Hospitals

Temporary clinics, mobile units, and makeshift storage locations may lack:

  • Temperature control
  • Protection from weather
  • Secure shelving
  • Pest control
  • These conditions promote rapid degradation and waste accumulation.

5. Environmental and Public Health Risks

  • Unsafe disposal such as dumping pharmaceuticals in open landfills, burning them at low temperature, or flushing into sewers can lead to:
  • Groundwater contamination
  • Accidental poisoning
  • Toxic emissions
  • Increased antimicrobial resistance
  • Long-term ecological damage
  • Thus, scientifically sound disposal practices are a critical aspect of emergency preparedness.

TYPES OF PHARMACEUTICAL WASTE IN EMERGENCIES [4].

Pharmaceutical waste in emergencies is diverse and requires precise classification to guide safe disposal.

Sr. No

Category

Description / Reason for Waste

1

Expired Pharmaceuticals

Medicines that exceed their expiration date become chemically unstable and potentially harmful.

2

Unused and Unopened Products

Often due to inappropriate donations or overstock. Although unused, they may be unsuitable for redistribution.

3

Contaminated or Damaged Medicines

Includes water-damaged tablets, heat-exposed vaccines, and products contaminated by debris or pathogens.

4

Controlled Substances

Opioids, psychotropics, and narcotics require specialised destruction under strict regulatory control.

5

Cytotoxic Waste

Chemotherapy drugs pose severe hazards and must be burned at very high temperatures (>1200°C).

6

Discontinued Therapeutic Classes

Medicines that are no longer recommended due to resistance or updated guidelines.

7

Packaging Waste

Outer cartons, blister packs, glass vials, polyethylene containers, and infusion bags contribute heavily to emergency medical waste volumes.

4. GENERAL PRINCIPLES OF WHO GUIDELINES [4-5].

WHO recommends that safe pharmaceutical disposal should be guided by the following core principles:

Table: -1 WHO core principles [6-8].

Sr. No

Core Principle

Description

Key Measures / Examples

1

Segregation by Type

Separate pharmaceuticals by category such as expired, cytotoxic, and controlled substances to prevent contamination and ensure appropriate disposal.

Use color-coded bins, separate storage for hazardous drugs.

2

Waste Minimization

Reduce unnecessary stock and avoid excess donations to limit waste generation.

Optimize inventory management, plan procurement according to need.

3

Environmental Safety

Ensure disposal methods do not harm the environment. Hazardous drugs should be incinerated or neutralized appropriately.

High-temperature incineration for cytotoxic drugs, chemical neutralization when applicable.

4

Regulatory Compliance

Follow national and international regulations for disposal of pharmaceutical waste.

Adhere to WHO and local legal guidelines, use licensed disposal services.

5

Documentation & Monitoring

Maintain accurate records of disposal activities to ensure accountability and traceability.

Keep disposal logs, perform periodic audits, monitor adherence to protocols.

WHO-RECOMMENDED DISPOSAL METHODS [9-10].

The WHO provides a structured hierarchy of disposal methods prioritising safety, environmental protection, and feasibility in resource-limited emergency settings. The method chosen must consider the pharmaceutical type, volume, local infrastructure, environmental regulations, and risk of diversion.

High-Temperature Incineration (Best Method)

High-temperature incineration (HTI) is considered the gold standard for pharmaceutical destruction.

Temperature Requirements

850–1200°C for general pharmaceuticals

>1200°C for cytotoxic drugs

Advantages

Effective destruction of active ingredients

Significant volume reduction (up to 95%)

Minimal environmental release when properly controlled

 Limitations

  • Rarely available in low-income or crisis environments
  • Expensive to operate
  • Requires trained staff, emission controls, and monitoring
  • HTI facilities are usually located in industrial zones, cement plants, or large hospitals.

 Medium-Temperature Incineration

Used when high-temperature units are not available.

Temperature Range 400–800°C

Suitable for

  • Antibiotics
  • Analgesics
  • Vitamins
  • Oral solids
  • Non-hazardous liquids

Concerns

Incomplete combustion can release toxic gases (dioxins, furans). WHO recommends this method only when HTI is unavailable.

Cement Kiln Co-Processing

An environmentally sound method used widely in emergencies.

Cement kilns operate at 1400–1600°C, ensuring complete destruction.

Pharmaceuticals are fed into the kiln with clinker materials.

No additional emissions because the process already uses high temperatures.

Advantages

  • Safe and efficient
  • Large capacity
  • Good for bulk waste disposal

Limitations

  • Requires agreement with cement plant operators
  • Transportation logistics must be secure

Encapsulation

This method involves the safe containment of pharmaceutical waste by encapsulating medicines within concrete-filled drums, thereby preventing environmental contamination. The process entails placing the pharmaceuticals into a large drum, adding immobilising materials such as cement, lime, and sand, and then sealing the drum with concrete before burial in a controlled landfill. This approach is particularly suitable for solid dosage forms, antibiotics, and short-term disposal of controlled medicines, offering a low-cost and effective means of secure pharmaceutical waste management[11].

Advantages

  • Prevents leaching
  • Simple and inexpensive

Limitations

  • Not suitable for liquids
  • Not ideal for cytotoxic waste

Inertisation

Inertisation is a pharmaceutical waste disposal method similar to encapsulation, where medicines are first ground and then mixed with a cement-lime mixture to form a stable, inert mass. This technique is particularly suitable for tablets, capsules, and combustible medicines, providing a safe and environmentally sound approach for the management of solid pharmaceutical waste [10].

Suitable for

  • Tablets and capsules
  • Combustible medicines

Advantages

  • Safe stabilization
  • Often used in emergencies

Limitations

  • Labour-intensive
  • Generates dust contamination if poorly executed

5.6 Chemical Degradation (Specialized Method)

Chemical degradation is a specialized technique for the disposal of pharmaceutical waste, wherein active pharmaceutical compounds are neutralized through the application of chemical agents such as potassium permanganate or bleach. This method is particularly suited for liquid pharmaceuticals, certain antineoplastic drugs, and disinfectants that cannot be safely disposed of through conventional means like incineration or landfilling. The process ensures that the bioactive or toxic properties of the waste are effectively destroyed, minimizing risks to human health and the environment. However, due to the technical complexity, need for careful handling of reactive chemicals, and requirement for controlled conditions, chemical degradation is generally not recommended for large-scale emergencies or mass pharmaceutical disposal [12-13].

Controlled Landfilling

Controlled landfilling is a method of pharmaceutical waste disposal in which medicines are securely buried in engineered landfill sites designed to minimize environmental contamination. In this approach, pharmaceutical waste particularly solid dosage forms, non-hazardous liquids, and expired or unused products is collected, segregated, and sometimes pretreated (e.g., immobilized or encapsulated) before being deposited in designated landfill cells[14]. These landfills are engineered with protective liners, leachate collection systems, and monitoring mechanisms to prevent the infiltration of hazardous substances into soil and groundwater. Controlled landfilling is considered a safe and practical method for managing pharmaceutical waste that cannot be incinerated or chemically degraded, especially in situations where other specialized disposal methods are not feasible. While it is relatively low-cost and effective for long-term containment, careful site selection, regulatory compliance, and ongoing environmental monitoring are essential to ensure that buried pharmaceuticals do not pose future health or ecological risks. This method is particularly useful for large volumes of non-hazardous or low-toxicity pharmaceutical waste generated in healthcare facilities and during emergency response operations [15].

PHARMACEUTICAL DISPOSAL DURING ACTIVE EMERGENCIES

During active emergencies such as natural disasters, epidemics, or humanitarian crises, large volumes of pharmaceutical products including expired, unused, damaged, or surplus medicines accumulate rapidly. Improper disposal in such situations can pose significant risks to human health, the environment, and public safety. Emergency contexts present unique challenges, including limited infrastructure, time constraints, and the urgent need to prevent diversion or misuse of controlled substances.

Effective disposal during active emergencies relies on a combination of strategies tailored to the type and hazard level of the pharmaceutical waste:

  1. Segregation and Inventory Control: Medicines should be categorized by type, hazard level, and expiry to facilitate safe handling and disposal.
  2. Low-Cost Containment Methods: Techniques such as immobilization in concrete-filled drums or inertisation allow secure containment of solid and combustible pharmaceuticals when other disposal options are limited.
  3. Chemical Degradation: For liquid pharmaceuticals or potent antineoplastics, controlled chemical neutralization may be employed, though this method is technically complex and limited to small volumes.
  4. Controlled Landfilling: Pre-treated or non-hazardous pharmaceuticals can be safely disposed of in engineered landfill sites with protective measures to prevent environmental contamination.
  5. Regulatory Compliance and Documentation: Even in emergencies, adherence to local, national, and WHO guidelines is crucial, along with proper record-keeping to track disposal activities and prevent misuse [16].

ENVIRONMENTAL AND PUBLIC HEALTH IMPACTS

Improper disposal of pharmaceutical waste has far-reaching consequences for both environmental and public health. Pharmaceuticals, particularly active pharmaceutical ingredients (APIs), can enter soil, surface water, and groundwater through leaching from landfills, improper incineration, or accidental spillage. This contamination may lead to the accumulation of bioactive compounds in aquatic organisms, disrupt ecosystems, and alter microbial populations. Antibiotics present in wastewater contribute to the development and spread of antimicrobial resistance (AMR), posing a global health threat. Cytotoxic drugs and antineoplastics, if released into the environment, may cause toxicity in non-target species and long-term ecological damage.

Controlled substances, narcotics, and psychoactive medications disposed of improperly can lead to accidental human exposure, poisoning, or illicit diversion. Even unused or expired medicines, though seemingly benign, can contribute to chronic low-level environmental contamination and potential health hazards when present in large quantities [17].

POLICY FRAMEWORKS AND REGULATORY GUIDELINES [18-19].

Effective pharmaceutical waste disposal requires strong policy frameworks supported by national legislation.

Sr. No

Category

Details / Responsibilities

1

National Regulatory Responsibilities

Governments must implement pharmaceutical waste regulations, approve disposal technologies, set emission standards, license disposal facilities, and ensure compliance through inspections.

2

International Standards and Guidance

WHO: Guidelines on drug management, waste segregation, safe disposal methods, environmental protection, and healthcare waste handling.UN (UNEP, UNDP): Focus on environmental impact assessments, green waste-management strategies, and Sustainable Development Goals (SDG 3, 6, 12, 13).International Health Regulations (IHR): Encourages strengthening national response capacities, including waste management during epidemics.

3

National Disaster Management Authorities (NDMA)

Incorporates pharmaceutical waste management into disaster preparedness plans, response guidelines, hospital disaster management planning, and emergency logistics protocols.

4

Legal Considerations

Disposal must comply with hazardous waste laws, environmental protection acts, controlled substances regulations, and transportation of hazardous materials rules. Penalties for non-compliance include fines, revocation of licenses, and closure of facilities.

ROLE OF PHARMACISTS AND HEALTH PROFESSIONALS

Pharmacists play a central role in minimizing pharmaceutical waste and ensuring safe Pharmacists and health professionals play a crucial role in minimizing pharmaceutical waste and ensuring safe disposal during all phases of emergencies. During preparedness, they plan appropriate inventories, avoid overstocking, and train healthcare staff on waste segregation, hazardous waste handling, and safe storage of expired medicines. During the emergency response, they identify unusable or damaged medicines, secure controlled substances to prevent diversion, and coordinate with humanitarian agencies for proper documentation and safe destruction. In the post-emergency recovery phase, pharmacists contribute to environmentally sound disposal planning, maintain accurate disposal records, and raise community awareness to promote safe return and disposal of medicines, thereby reducing environmental contamination [19].

TECHNOLOGICAL ADVANCEMENTS IN PHARMACEUTICAL DISPOSAL[18-20].

Recent years have seen significant technological progress in pharmaceutical waste management, aimed at improving safety, efficiency, and environmental protection. Key advancements include:

  1. High-Temperature Incineration: Modern incinerators equipped with emission control systems efficiently destroy hazardous and cytotoxic pharmaceuticals, minimizing toxic residue and airborne pollutants.
  2. Plasma Gasification: Uses extremely high temperatures to convert pharmaceutical waste into inert gas and slag, providing a clean alternative to conventional incineration for highly toxic or persistent compounds.
  3. Chemical Degradation and Neutralization: Advanced chemical treatment technologies allow selective neutralization of APIs, particularly for liquid pharmaceuticals and antineoplastics, ensuring safe disposal of hazardous compounds.
  4. Encapsulation and Immobilization Techniques: Improved cement-based encapsulation, inertization, and concrete-drum methods ensure long-term containment of solid pharmaceuticals, including controlled substances, reducing leachate risks in landfills.
  5. Automated Waste Segregation Systems: Use of robotics, AI, and sensor-based sorting systems in healthcare facilities to segregate hazardous and non-hazardous waste efficiently, reducing human exposure and operational errors.
  6. Eco-friendly Waste-to-Energy Technologies: Conversion of non-recyclable pharmaceutical waste into energy using pyrolysis and bioenergy systems, contributing to sustainable waste management practices.

13. CASE STUDIES OF PHARMACEUTICAL DISPOSAL IN EMERGENCIES[17-18].

Real-world emergencies provide insight into the challenges and successful strategies for pharmaceutical waste management.

Examining real-world experiences provides valuable insights into challenges, strategies, and best practices for pharmaceutical waste management during emergencies. Key case studies include:

  1. 2010 Haiti Earthquake
  • Massive influx of donated medicines led to overstocking, expiration, and accumulation of unusable pharmaceuticals.
  • NGOs and local authorities implemented segregation, prioritization, and controlled disposal through incineration and secure landfilling.
  • Highlighted the need for pre-planned inventory management and donor coordination.
  1. Ebola Outbreak, West Africa (2014–2016)
  • High volumes of antiviral drugs and personal protective equipment (PPE) required rapid, safe disposal.
  • Chemical neutralization and high-temperature incineration were used for contaminated liquid and solid waste.
  • Emphasized the importance of biosafety protocols and international guidance adherence.
  1. COVID-19 Pandemic (Global, 2020–2022)
  • Surge in vaccines, antivirals, and single-use medical devices generated unprecedented pharmaceutical and medical waste.
  • Hospitals and vaccination centers adopted automated segregation, encapsulation for expired doses, and controlled landfilling.
  • Demonstrated the need for scalable waste management systems and robust regulatory frameworks in public health emergencies.

CHALLENGES IN LOW-RESOURCE AND EMERGENCY SETTINGS [19].

Pharmaceutical disposal in low-resource and emergency settings faces unique operational, logistical, and regulatory challenges that can compromise both human health and environmental safety:

  1. Infrastructure Limitations:
  • Lack of modern incineration facilities or secure landfills.
  • Inadequate storage areas for segregation of hazardous and non-hazardous pharmaceuticals.
  1. Resource Constraints:
  • Limited availability of trained personnel to handle hazardous waste safely.
  • Insufficient funding for advanced disposal technologies such as plasma gasification or chemical neutralization.
  1. High Volume of Waste:
  • Sudden influx of donations during emergencies leads to overstocking and accumulation of expired or unusable medicines.
  • Difficulty in tracking and prioritizing disposal of large quantities of pharmaceuticals.
  1. Regulatory Gaps:
  • Weak enforcement of national guidelines or lack of clear policies for emergency pharmaceutical disposal.
  • Inconsistent adherence to international standards such as WHO or UNEP recommendations.
  1. Environmental and Health Risks:
  • Increased risk of contamination of soil, water, and local ecosystems due to improper disposal.
  • Potential for diversion, accidental poisoning, or misuse of controlled substances.
  1. Logistical Challenges:
  • Difficult terrain, disrupted transport networks, and security issues may delay collection and disposal.
  • Limited access to protective equipment and monitoring tools for waste handlers.

FUTURE DIRECTIONS [16].

To improve pharmaceutical waste management in emergencies, several strategic measures are recommended:

  • Strengthen Global Donation Policies: Enforce WHO donation guidelines to reduce overstocking and accumulation of unusable medicines.
  • Invest in Low-Cost Disposal Technologies: Implement mobile incinerators, solar thermal treatment, and portable encapsulation units to enable safe disposal in low-resource settings.
  • Digital Inventory and Supply-Chain Systems: Use digital platforms to track expiry dates, prevent overstock, and manage donations efficiently.
  • Regional Pharmaceutical Waste Centers: Establish shared regional facilities for countries lacking incineration or specialized disposal infrastructure.
  • Green and Sustainable Disposal Innovations: Promote research into eco-friendly biodegradation, microbial breakdown, and enzymatic destruction of pharmaceuticals.
  • Enhanced Training for Pharmacists: Equip healthcare professionals with skills to minimize waste, potentially preventing 20–40% of pharmaceutical loss during emergencies.
  • Strengthening International Collaboration: Encourage coordinated efforts between UN agencies, WHO, NGOs, and national governments to ensure efficient and safe pharmaceutical disposal.

CONCLUSION

Effective pharmaceutical disposal in and after emergencies is critical to safeguarding public health, preventing environmental contamination, and reducing the risk of antimicrobial resistance. WHO guidelines offer a comprehensive framework that combines safety, practicality, and environmental responsibility. Emergencies often lead to large quantities of expired, damaged, or unsuitable medicines, especially when unsolicited donations occur. Adoption of WHO-recommended disposal methods such as high-temperature incineration, cement kiln co-processing, encapsulation, and inertisation ensures safe and environmentally acceptable destruction of pharmaceutical waste.

Pharmacists, policymakers, hum anitarian agencies, and health professionals play essential roles in prevention, planning, and execution of disposal strategies. With rising global emergencies, climate change, and evolving disease patterns, strengthening pharmaceutical waste management systems is more important than ever. A coordinated global effort, supported by robust regulations, sustainable disposal technologies, and efficient logistics, is needed to minimize waste, protect communities, and preserve environmental health.

REFERENCES

  1. World Health Organization. Guidelines for Safe Disposal of Unwanted Pharmaceuticals in and after Emergencies. Geneva: WHO; 1999.
  2. World Health Organization. Technical Notes on Drinking-Water, Sanitation and Hygiene in Emergencies. WHO; 2013.
  3. United Nations Environment Programme. Environmental Management Guidelines. UNEP; 2010.
  4. World Health Organization. Health-Care Waste Management: Rapid Assessment Tool for Emergencies. WHO; 2012.
  5. World Health Organization. Safe Management of Wastes from Health-Care Activities. 2nd ed. Geneva: WHO; 2014.
  6. World Health Organization. Guidelines for Drug Donations. WHO; 2010.
  7. United Nations Office for the Coordination of Humanitarian Affairs. Humanitarian Logistics in Emergencies. OCHA; 2017.
  8. World Health Organization. Antimicrobial Resistance: Global Report on Surveillance. Geneva: WHO; 2014.
  9. Food and Agriculture Organization. Environmental Impact of Pharmaceuticals. FAO; 2018.
  10. World Health Organization. International Health Regulations (IHR). Geneva: WHO; 2005.
  11. United Nations Environment Programme. Disaster Waste Management Guidelines. UNEP; 2011.
  12. World Health Organization. Pharmacist’s Role in Emergency Response. WHO; 2018.
  13. United Nations Development Programme. Sustainable Waste Management Technologies. UNDP; 2020.
  14. World Health Organization. Health Action in Crises: Technical Guidance Series. WHO; 2010.
  15. Médicins Sans Frontières (MSF). Waste Management Guidelines in Humanitarian Settings. MSF; 2015.
  16. United Nations Children’s Fund (UNICEF). Cold Chain Logistics in Emergencies. UNICEF; 2016.
  17. World Health Organization. Vaccine Management Handbook. WHO; 2015.
  18. Pan American Health Organization. Emergency Medical Supply Chain Management. PAHO; 2018.
  19. World Health Organization. COVID-19 Vaccine Wastage Guidelines. WHO; 2021.
  20. International Committee of the Red Cross. Pharmaceutical Logistics and Waste Protocols. ICRC; 2019.

Reference

  1. World Health Organization. Guidelines for Safe Disposal of Unwanted Pharmaceuticals in and after Emergencies. Geneva: WHO; 1999.
  2. World Health Organization. Technical Notes on Drinking-Water, Sanitation and Hygiene in Emergencies. WHO; 2013.
  3. United Nations Environment Programme. Environmental Management Guidelines. UNEP; 2010.
  4. World Health Organization. Health-Care Waste Management: Rapid Assessment Tool for Emergencies. WHO; 2012.
  5. World Health Organization. Safe Management of Wastes from Health-Care Activities. 2nd ed. Geneva: WHO; 2014.
  6. World Health Organization. Guidelines for Drug Donations. WHO; 2010.
  7. United Nations Office for the Coordination of Humanitarian Affairs. Humanitarian Logistics in Emergencies. OCHA; 2017.
  8. World Health Organization. Antimicrobial Resistance: Global Report on Surveillance. Geneva: WHO; 2014.
  9. Food and Agriculture Organization. Environmental Impact of Pharmaceuticals. FAO; 2018.
  10. World Health Organization. International Health Regulations (IHR). Geneva: WHO; 2005.
  11. United Nations Environment Programme. Disaster Waste Management Guidelines. UNEP; 2011.
  12. World Health Organization. Pharmacist’s Role in Emergency Response. WHO; 2018.
  13. United Nations Development Programme. Sustainable Waste Management Technologies. UNDP; 2020.
  14. World Health Organization. Health Action in Crises: Technical Guidance Series. WHO; 2010.
  15. Médicins Sans Frontières (MSF). Waste Management Guidelines in Humanitarian Settings. MSF; 2015.
  16. United Nations Children’s Fund (UNICEF). Cold Chain Logistics in Emergencies. UNICEF; 2016.
  17. World Health Organization. Vaccine Management Handbook. WHO; 2015.
  18. Pan American Health Organization. Emergency Medical Supply Chain Management. PAHO; 2018.
  19. World Health Organization. COVID-19 Vaccine Wastage Guidelines. WHO; 2021.
  20. International Committee of the Red Cross. Pharmaceutical Logistics and Waste Protocols. ICRC; 2019.

Photo
Satyabhavana Sakre
Corresponding author

School of Pharmacy and Research, People’s University, Bhopal, Madhya Pradesh, India 462037

Photo
Bhaskar Kumar Gupta
Co-author

School of Pharmacy and Research, People’s University, Bhopal, Madhya Pradesh, India 462037

Photo
Aniket Kumar
Co-author

School of Pharmacy and Research, People’s University, Bhopal, Madhya Pradesh, India 462037

Photo
Vishwajeet Kumar
Co-author

School of Pharmacy and Research, People’s University, Bhopal, Madhya Pradesh, India 462037

Satyabhavana Sakre, Bhaskar Kumar Gupta, Aniket Kumar, Vishwajeet Kumar, Strategies for the Safe Management and Disposal of Unused and Expired Pharmaceuticals in Emergency and Post-Emergency Settings: A Comprehensive Review, Int. J. of Pharm. Sci., 2026, Vol 4, Issue 1, 50-60. https://doi.org/10.5281/zenodo.18116164

More related articles
Navigating Of DEVIC’S Diseasse: Symptoms, Diagno...
Daphne Sherine, Thrisha R., Srimathi P., Oviya M. Kaviyarasan P....
Formulation And Evaluation Fast Disintegrating Tab...
Harshal Gosavi, Dr. Avish Maru, Jayshree Bhadane, Nilesh Pawar, ...
Targeted Therapies in Blood Cancer...
Sanchit Armal, Radheshyam Azade, Om Avhale, Prashant Ingle, Dr. S...
Natural Polymers as Excipient in Formulation of Novel Drug Delivery System...
Yukti Mahajan, Dev Raj Sharma, Pravin Kumar, Mahender Singh Ashawat, ...
Formulation And Evaluation Of Mosquitoes Repellent Candles ...
Shaily Saini , Anshika Singh, Hansika Varshney, ...
T Cell Line Treatment for Cancer Using Tumor-Infiltrating Lymphocytes ...
Swathi Madhavan, T. Keerthana, A. Sowmiya, D. Kilimozhi, ...
Related Articles
A Clinical Perspective on Mucoadhesive Implants...
Swarup Dhore, Swaraj Barne , Yashad Chavan , Yashodeep Gore , ...
A Review on Method Development for Simultaneous Estimation of Itraconazole and T...
Vanita B. Katore, Hemlata S.Bhawar, Geeta Nhavale, Rahul Godge, Sabafarin H.Shaikh, Mayur S.Bhosale,...
Car-T Cell Therapy: A Review ...
Patil Bhavesh, Sayyed A. Kirmani , Kawade R. M. , ...
Navigating Of DEVIC’S Diseasse: Symptoms, Diagnosis, And Care...
Daphne Sherine, Thrisha R., Srimathi P., Oviya M. Kaviyarasan P., ...
More related articles
Navigating Of DEVIC’S Diseasse: Symptoms, Diagnosis, And Care...
Daphne Sherine, Thrisha R., Srimathi P., Oviya M. Kaviyarasan P., ...
Formulation And Evaluation Fast Disintegrating Tablet: A Comprehensive Review...
Harshal Gosavi, Dr. Avish Maru, Jayshree Bhadane, Nilesh Pawar, ...
Targeted Therapies in Blood Cancer...
Sanchit Armal, Radheshyam Azade, Om Avhale, Prashant Ingle, Dr. Shivshankar Mhaske, ...
Navigating Of DEVIC’S Diseasse: Symptoms, Diagnosis, And Care...
Daphne Sherine, Thrisha R., Srimathi P., Oviya M. Kaviyarasan P., ...
Formulation And Evaluation Fast Disintegrating Tablet: A Comprehensive Review...
Harshal Gosavi, Dr. Avish Maru, Jayshree Bhadane, Nilesh Pawar, ...
Targeted Therapies in Blood Cancer...
Sanchit Armal, Radheshyam Azade, Om Avhale, Prashant Ingle, Dr. Shivshankar Mhaske, ...